The latest closing stock price for Denali Therapeutics as of May 23, 2025 is 13.42.
An investor who bought $1,000 worth of Denali Therapeutics stock at the IPO in 2017 would have $-374 today, roughly 0 times their original investment - a -6.48% compound annual growth rate over 7 years.
The all-time high Denali Therapeutics stock closing price was 93.56 on December 22, 2020.
The Denali Therapeutics 52-week high stock price is 33.33, which is 148.4% above the current share price.
The Denali Therapeutics 52-week low stock price is 10.57, which is 21.2% below the current share price.
The average Denali Therapeutics stock price for the last 52 weeks is 21.65.
An investor who bought $1,000 worth of Denali Therapeutics stock at the IPO in 2017 would have $-374 today, roughly 0 times their original investment - a -6.48% compound annual growth rate over 7 years.
The all-time high Denali Therapeutics stock closing price was 93.56 on December 22, 2020.
The Denali Therapeutics 52-week high stock price is 33.33, which is 148.4% above the current share price.
The Denali Therapeutics 52-week low stock price is 10.57, which is 21.2% below the current share price.
The average Denali Therapeutics stock price for the last 52 weeks is 21.65.